Cargando…

Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial

BACKGROUND: Children < 5 years old in contact with TB cases are at high risk for developing severe and fatal forms of TB. Contact investigation, BCG vaccination, and isoniazid preventive therapy (IPT) are the most effective strategies to prevent TB among children. However, the implementation of I...

Descripción completa

Detalles Bibliográficos
Autores principales: Otero, L., Zetola, N., Campos, M., Zunt, J., Bayer, A., Curisinche, M., Ochoa, T., Reyes, M., Vega, V., Van der Stuyft, P., Sterling, TR.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871424/
https://www.ncbi.nlm.nih.gov/pubmed/36694242
http://dx.doi.org/10.1186/s13063-022-07062-6
_version_ 1784877168846700544
author Otero, L.
Zetola, N.
Campos, M.
Zunt, J.
Bayer, A.
Curisinche, M.
Ochoa, T.
Reyes, M.
Vega, V.
Van der Stuyft, P.
Sterling, TR.
author_facet Otero, L.
Zetola, N.
Campos, M.
Zunt, J.
Bayer, A.
Curisinche, M.
Ochoa, T.
Reyes, M.
Vega, V.
Van der Stuyft, P.
Sterling, TR.
author_sort Otero, L.
collection PubMed
description BACKGROUND: Children < 5 years old in contact with TB cases are at high risk for developing severe and fatal forms of TB. Contact investigation, BCG vaccination, and isoniazid preventive therapy (IPT) are the most effective strategies to prevent TB among children. However, the implementation of IPT faces challenges at several stages of the cascade of care of TB infection among children, particularly those less than 5 years old. In Peru, a large proportion of children do not complete IPT, which highlights the need to design effective interventions that enhance preventive therapy adherence and completion. Although the body of evidence for such interventions has grown, interventions in medium TB incidence settings are lacking. This study aims to test the effectiveness, acceptability, and feasibility of an intervention package to increase information and motivation to complete IPT among children < 5 who have been prescribed IPT. METHODS: An open-label, cluster-randomized superiority trial will be conducted in two districts in South Lima, Peru. Thirty health facilities will be randomized as clusters, 10 to the intervention and 20 to control (standard of care). We aim to recruit 10 children from different households in each cluster. Participants will be caretakers of children aged < 5 years old who initiated IPT. The intervention consists of educational material, and short message services (SMS) reminders and motivators. The primary outcomes will be the proportion of children who picked up > 90% of the 24 weeks of IPT (22 pick-ups) and the proportion of children who picked up the 24 weeks of IPT. The standard of care is a weekly pick-up with monthly check-ups in a health facility. Feasibility and acceptability of the intervention will be assessed through an interview with the caretaker. DISCUSSION: Unfavorable outcomes of TB in young children, high effectiveness of IPT, and low rates of IPT completion highlight the need to enhance adherence and completion of IPT among children < 5 years old. Testing of a context-adapted intervention is needed to improve IPT completion rates and therefore TB prevention in young children. TRIAL REGISTRATION: ClinicalTrials.gov NCT03881228. Registered on March 19, 2019. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-07062-6.
format Online
Article
Text
id pubmed-9871424
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98714242023-01-25 Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial Otero, L. Zetola, N. Campos, M. Zunt, J. Bayer, A. Curisinche, M. Ochoa, T. Reyes, M. Vega, V. Van der Stuyft, P. Sterling, TR. Trials Study Protocol BACKGROUND: Children < 5 years old in contact with TB cases are at high risk for developing severe and fatal forms of TB. Contact investigation, BCG vaccination, and isoniazid preventive therapy (IPT) are the most effective strategies to prevent TB among children. However, the implementation of IPT faces challenges at several stages of the cascade of care of TB infection among children, particularly those less than 5 years old. In Peru, a large proportion of children do not complete IPT, which highlights the need to design effective interventions that enhance preventive therapy adherence and completion. Although the body of evidence for such interventions has grown, interventions in medium TB incidence settings are lacking. This study aims to test the effectiveness, acceptability, and feasibility of an intervention package to increase information and motivation to complete IPT among children < 5 who have been prescribed IPT. METHODS: An open-label, cluster-randomized superiority trial will be conducted in two districts in South Lima, Peru. Thirty health facilities will be randomized as clusters, 10 to the intervention and 20 to control (standard of care). We aim to recruit 10 children from different households in each cluster. Participants will be caretakers of children aged < 5 years old who initiated IPT. The intervention consists of educational material, and short message services (SMS) reminders and motivators. The primary outcomes will be the proportion of children who picked up > 90% of the 24 weeks of IPT (22 pick-ups) and the proportion of children who picked up the 24 weeks of IPT. The standard of care is a weekly pick-up with monthly check-ups in a health facility. Feasibility and acceptability of the intervention will be assessed through an interview with the caretaker. DISCUSSION: Unfavorable outcomes of TB in young children, high effectiveness of IPT, and low rates of IPT completion highlight the need to enhance adherence and completion of IPT among children < 5 years old. Testing of a context-adapted intervention is needed to improve IPT completion rates and therefore TB prevention in young children. TRIAL REGISTRATION: ClinicalTrials.gov NCT03881228. Registered on March 19, 2019. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-07062-6. BioMed Central 2023-01-24 /pmc/articles/PMC9871424/ /pubmed/36694242 http://dx.doi.org/10.1186/s13063-022-07062-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Otero, L.
Zetola, N.
Campos, M.
Zunt, J.
Bayer, A.
Curisinche, M.
Ochoa, T.
Reyes, M.
Vega, V.
Van der Stuyft, P.
Sterling, TR.
Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial
title Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial
title_full Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial
title_fullStr Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial
title_full_unstemmed Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial
title_short Isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in Lima, Peru: study protocol for an open-label, cluster-randomized superiority trial
title_sort isoniazid preventive therapy completion in children under 5 years old who are contacts of tuberculosis cases in lima, peru: study protocol for an open-label, cluster-randomized superiority trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871424/
https://www.ncbi.nlm.nih.gov/pubmed/36694242
http://dx.doi.org/10.1186/s13063-022-07062-6
work_keys_str_mv AT oterol isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT zetolan isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT camposm isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT zuntj isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT bayera isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT curisinchem isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT ochoat isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT reyesm isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT vegav isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT vanderstuyftp isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial
AT sterlingtr isoniazidpreventivetherapycompletioninchildrenunder5yearsoldwhoarecontactsoftuberculosiscasesinlimaperustudyprotocolforanopenlabelclusterrandomizedsuperioritytrial